Astellas Pharma Inc (PK) (ALPMF)
USOTC
Year End March 30 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | JPY (¥) | |
Total Assets | 1.82T | 1.86T | 1.9T | 2.32T | 2.27T | 2.33T | 2.46T | 3.57T |
Total Current Assets | 876.67B | 835.25B | 857.16B | 867.51B | 872.59B | 923.35B | 1.05T | 1.19T |
Cash and Equivalents | 331.8B | 328.67B | 297.48B | 313.13B | 326.13B | 315.99B | 376.84B | 317.97B |
Total Non-Current Assets | 1.27T | 1.27T | 1.26T | 1.29T | 1.39T | 1.46T | 1.51T | 1.6T |
Total Liabilities | 549.09B | 589.92B | 639.25B | 1.03T | 887.51B | 872.09B | 948.56B | 1.97T |
Total Current Liabilities | 399.86B | 421.62B | 497.67B | 798.71B | 592.37B | 687.41B | 726.03B | 1.29T |
Total Non-Current Liabilities | 150.37B | 169.2B | 141.59B | 299.51B | 295.14B | 184.68B | 222.53B | 1.14T |
Total Equity | 1.27T | 1.27T | 1.26T | 1.29T | 1.39T | 1.46T | 1.51T | 1.6T |
Common Equity | 103B | 103B | 103B | 212.99B | 270.37B | 350.51B | 443.64B | 103B |
Retained Earnings | 1.01T | 976.08B | 991.96B | 905.85B | 953.29B | 944.26B | 908.16B | 809.4B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.